Contract Pharmacal

Contract Pharmacal Corp. (CPC) is a long-established, family-led private CDMO with over five decades of experience in the development, manufacturing, and packaging of solid-dose pharmaceuticals, OTC drugs, and dietary supplements. The company operates as a full-service partner, leveraging its extensive R&D capabilities, high-volume manufacturing capacity, and regulatory expertise to help clients—including major brands and distributors—bring products to market faster. CPC's business model is built on quality assurance, customization, and a vertically integrated process from raw materials to finished, packaged goods, positioning it as a trusted partner in a competitive contract manufacturing landscape.

Integrated contract development and manufacturing organization (CDMO) platform for solid-dose pharmaceuticals, OTC drugs, and dietary supplements. Includes formulation development, analytical services, regulatory navigation, high-volume manufacturing, and full-service packaging.

CPC competes in a fragmented but competitive CDMO market against large, global public players (e.g., Catalent, Lonza, Recipharm) and numerous smaller, specialized firms. Its differentiation lies in its deep expertise in solid-dose forms, family-led focus on quality and service, full-service vertical integration, and long-standing client relationships in both pharma and retail sectors.